Showing posts tagged with: Avestin

Commercial Scale High Pressure Homogenisation: Avestin EmulsiFlex C160

by biopharmaszymon in BPS News, BPS Right Sidebar Content

Within the pharmaceutical, biotechnology and industries alike, a common challenge is the replication of results when moving from the laboratory scale to commercial scale. Many lab scale instruments can differ significantly from the equipment required to produce large volumes of the same materi...Read more

High Pressure Homogenisation for the Cell Disruption of Algae

by gstrongitharm in BPS News, BPS Right Sidebar Content

Source: CHEMISTRYWORLD Extraction of biofuels and bio-products from algae is on the rise. Recent years has seen a substantial increase in demand for food, energy and valuable chemicals, which has led to the rise of R&D on renewable, novel and sustainable resources [1]. The ability o...Read more

High Pressure Homogeniser Product Focus: Avestin EmulsiFlex C55

by biopharmaszymon in Uncategorized

  The difference in throughput between a benchtop and production scale high pressure homogneiser can be enormous, and so there is a need to bridge the gap between the two, via a system that offers all of the accessories and GMP-compliant modifications that a production-scale unit would ...Read more

For Sale – Ex-Demo Avestin EmulsiFlex-C3

by in BPS News, BPS Right Sidebar Content

Refurbished ex-demo Avestin EmulsiFlex-C3 High Pressure Homogeniser £15,500 (incl. 3 month warranty and delivery within the UK & Ireland)   This system has been fully refurbished to current manufacturing standards, and is supplied fully tested, with new fitted parts, 3 month war...Read more

How the Adaptability of Liposomes Assists in Overcoming Today’s Drug Delivery Challenges

by in BPS News, BPS Right Sidebar Content

  A common challenge during modern drug development is overcoming low bioavailability. As a result, investigations in to the use of liposomes as a potential drug carrier suggest these may offer a promising solution. It is no surprise the study of liposome-drug encapsulation is a...Read more

Why you should chose extrusion for your liposomal enhancement

by biopharmacharis in BPS News

[vc_row][vc_column][vc_column_text] Extrusion for Unilamellar Liposome Formation Source: F. Caillaud/CNRS Photothèque/SAGASCIENCE   The production and study of liposomes is becoming an increasing field of review, due their biocompatibility, biodegradability, low toxicity, and abili...Read more

‘Introduction to Homogenisation’ Guide Now Available

by in BPS News, BPS Right Sidebar Content

High pressure homogenisation is a key technology  for particle size reduction, particle or suspension stability, sample homogeneity and nanomolecular disruption. The benefits of this technology include extraction of valuable intracellular products and improving shelf life and potency of pharmaceu...Read more

Application Note: High Pressure Homogenisation and Protein Expression

by in Application and Tech Notes

Inspiralis is a company based in Norwich which specialises in providing topoisomerases, ligases and other DNA-modifying proteins which are used in the drug-discovery process by the pharmaceutical industry and academia. Topoisomerases are proteins which alter the topology of DNA, preventing it bec...Read more

Nano Particles, an Effective Means for Drug Delivery

by in BPS News, BPS Right Sidebar Content

March 2015 Advances in drug discovery technologies and combinatorial chemistry techniques have led to identification of a number of compounds with good therapeutic potential. However, the number of insoluble drug candidates has increased in recent years with almost 70%1 of new drug candidates sh...Read more

Drug Discovery – New challenges, new solutions

by in BPS News, BPS Right Sidebar Content

June 2014 Recombinant and heterologous expression of proteins has been a common practice in industry and academia for the last few decades. It is commonly used with technologies including molecular biology, DNA cloning, protein analytics and purification for discovery of new drugs and drug targe...Read more